HCID 86744189、化合物 → Pirazolac
反応式
[F:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[CH:12]=[C:11]([C:13]3[CH:18]=[CH:17][C:16]([Cl:19])=[CH:15][CH:14]=3)[C:10]([CH2:20][C:21]([O-:23])=[O:22])=[N:9]2)=[CH:4][CH:3]=1>[Pd]>[F:1][C:2]1[CH:3]=[CH:4][C:5]([N:8]2[CH:12]=[C:11]([C:13]3[CH:18]=[CH:17][C:16]([Cl:19])=[CH:15][CH:14]=3)[C:10]([CH2:20][C:21]([OH:23])=[O:22])=[N:9]2)=[CH:6][CH:7]=1参加物
3
試薬・触媒・溶媒 1
実験手順
1,49 Grams (3 mM) of the benzohydryl [1-(4-fluorophenyl)-4-(4-chlorophenyl)-1H-pyrazol-3-yl]-acetate are dissolved in 40 ml of tetrahydroflurane. To the solution 0,4 g of Pd on charcoal (10%) are added, then the mixture is hydrogenated at room temperature and pressure. At the end of the reaction the catalysator is filtered, the solvent evaporated and the product crystallized from acetic acid/ethanol. The title product is obtained in almost quantitative yield.
後処理
- customis hydrogenated at room temperature
- customAt the end of the reaction the catalysator
- filtrationis filtered
- customthe solvent evaporated
- customthe product crystallized from acetic acid/ethanol
出典と根拠
- ORDレコード
- ord-f2ab52f269b44a928d2852f75c3558b9
- 出典データセット
- uspto-grants-1990_08
- 特許番号
- US04952702
反応ノート
読み込み中…